High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation (ASCT) Has a Significant but Transient Impact on Quality of Life: Lessons From the Chronic Lymphocytic Leukemia (CLL) ASCT Study by the CLL Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Author(s):: Wreede, L.C. de (0000-0002-7667-9369); Watson, M.; Milligan, D.; Michallet, M.; Dreger, P.; Os, M. van; Dearden, C.E.; Cordonnier, C.; Leporrier, M.; Koza, V.; Homewood, J.; Corront, B.; Baerlocher, G.M.; Herr, W.; Niederwieser, D.; Sutton, L.; Witte, T.M. de; Schetelig, J.

Published: 2011
Publication type: Article / Letter to editor

Date issued: 2011-11-18
Language: English
Is part of: Blood (2011), Vol. 118, no. 21, p. 868-869
hdl: 1887/97950